Articles written by: Ash Maslow

AVROBIO, Inc. (AVRO) Analysts See $-0.58 EPS; Gsa Capital Partners Llp Has Raised Varonis Sys (VRNS) Position

AVROBIO, Inc. (AVRO) Analysts See $-0.58 EPS; Gsa Capital Partners Llp Has Raised Varonis Sys (VRNS) Position

Analysts expect AVROBIO, Inc. (NASDAQ:AVRO) to report $-0.58 EPS on February, 12.After having $-0.49 EPS previously, AVROBIO, Inc.’s analysts see 18.37% EPS growth. The stock decreased 7.02% or $1 during the last trading session, reaching $13.24. About 42,206 shares traded. AVROBIO, Inc. (NASDAQ:AVRO) has 0.00% since January 24, 2018 and […]

Celgene Co. (CELG) Shares Bought by HCR Wealth Advisors

Celgene Co. (CELG) Shares Bought by HCR Wealth Advisors

HCR Wealth Advisors lifted its position in Celgene Co. (NASDAQ:CELG) by 7.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,949 shares of the biopharmaceutical company‚Äôs stock after purchasing an additional 824 shares during the […]

Keysight Technologies, Inc. (KEYS) Reaches $70.92 52-Week High; Amerco (UHAL) Sentiment Is 1.14

Keysight Technologies, Inc. (KEYS) Reaches $70.92 52-Week High; Amerco (UHAL) Sentiment Is 1.14

Amerco (UHAL) investors sentiment decreased to 1.14 in Q3 2018. It’s down -0.81, from 1.95 in 2018Q2. The ratio worsened, as 90 investment managers increased or started new positions, while 79 decreased and sold their stakes in Amerco. The investment managers in our database reported: 6.89 million shares, down from […]

Exclusive Coin (EXCL) targets $0.189401036 while having -4.90% drop for a day

Exclusive Coin (EXCL) had a bad 24 hours as the crypto declined $-0.00887540000000001 or -4.90% trading at $0.17218276. According to Cryptocoin Analysts, Exclusive Coin (EXCL) eyes $0.189401036 target on the road to $0.485260425348312. EXCL last traded at Upbit exchange. It had high of $0.1864899048 and low of $0.1717922424 for January […]

Reviewing LogicBio Therapeutics Inc. (LOGC)’s and Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS)’s results

We are contrasting LogicBio Therapeutics Inc. (NASDAQ:LOGC) and Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) on their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LogicBio Therapeutics Inc. N/A […]